Manas K Akmatov1, Rafael T Mikolajczyk. 1. Department of Infection Genetics, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany. manas.akmatov@helmholtz-hzi.de
Abstract
BACKGROUND: This study assessed the extent of delays in childhood vaccinations and examined sociodemographic correlates of delayed and missing vaccinations. METHODS: Datasets from the 2005-7 Multiple Indicator Cluster Surveys from 31 countries were used. Information on vaccinations was based on vaccination cards. Survival analysis was applied to assess age-specific vaccination rates, and multilevel logistic regression analysis was used to assess factors associated with delayed and missing vaccinations. RESULTS: The median vaccination coverage across all countries varied from 91% measles-containing vaccine (MCV) to 98% bacille Calmette-Guérin vaccine (BCG). The median fraction of timely administered vaccinations was 65% (range 14.5-97.2%) for BCG, 67% (11.6-89.3%) for the first dose of vaccine against diphtheria, tetanus and pertussis (DTP1), 41% (10.8-82.1%) for DTP3, 68% (29.7-90.3%) for the first dose of polio vaccine (polio1), 38% (10.5-81.0%) for polio3 and 51% (22.3-91.1%) for MCV. The median of the median delays across all countries was 2.1 weeks (IQR 0.9-3.0) for BCG, 2.4 weeks (1.5-3.1) for DTP1; 6.3 weeks (3.3-9.0) for DTP3; 2.0 weeks (1.3-3.1) for polio1, 6.6 weeks (4.3-9.3) for polio3 and 4.1 weeks (2.5-5.8) for MCV. A higher number of children in households and lower socioeconomic status were associated with delayed and missing vaccinations; however, the effects of socioeconomic gradient varied by country. CONCLUSION: Most countries achieved high up-to-date vaccination coverage. However, there were substantial vaccination delays. Collecting information on the timeliness of vaccination in national surveillance systems will provide a more complete view of vaccination coverage. Missing and delayed vaccinations can be addressed jointly in prevention programmes.
BACKGROUND: This study assessed the extent of delays in childhood vaccinations and examined sociodemographic correlates of delayed and missing vaccinations. METHODS: Datasets from the 2005-7 Multiple Indicator Cluster Surveys from 31 countries were used. Information on vaccinations was based on vaccination cards. Survival analysis was applied to assess age-specific vaccination rates, and multilevel logistic regression analysis was used to assess factors associated with delayed and missing vaccinations. RESULTS: The median vaccination coverage across all countries varied from 91% measles-containing vaccine (MCV) to 98% bacille Calmette-Guérin vaccine (BCG). The median fraction of timely administered vaccinations was 65% (range 14.5-97.2%) for BCG, 67% (11.6-89.3%) for the first dose of vaccine against diphtheria, tetanus and pertussis (DTP1), 41% (10.8-82.1%) for DTP3, 68% (29.7-90.3%) for the first dose of polio vaccine (polio1), 38% (10.5-81.0%) for polio3 and 51% (22.3-91.1%) for MCV. The median of the median delays across all countries was 2.1 weeks (IQR 0.9-3.0) for BCG, 2.4 weeks (1.5-3.1) for DTP1; 6.3 weeks (3.3-9.0) for DTP3; 2.0 weeks (1.3-3.1) for polio1, 6.6 weeks (4.3-9.3) for polio3 and 4.1 weeks (2.5-5.8) for MCV. A higher number of children in households and lower socioeconomic status were associated with delayed and missing vaccinations; however, the effects of socioeconomic gradient varied by country. CONCLUSION: Most countries achieved high up-to-date vaccination coverage. However, there were substantial vaccination delays. Collecting information on the timeliness of vaccination in national surveillance systems will provide a more complete view of vaccination coverage. Missing and delayed vaccinations can be addressed jointly in prevention programmes.
Authors: Richard G Wamai; Claudine Akono Ayissi; Geofrey O Oduwo; Stacey Perlman; Edith Welty; Simon Manga; Javier Gordon Ogembo Journal: J Community Health Date: 2012-10
Authors: Juan F Sanchez; Eric S Halsey; Angela M Bayer; Martin Beltran; Hugo R Razuri; Daniel E Velasquez; Vitaliano A Cama; Paul C F Graf; Antonio M Quispe; Ryan C Maves; Joel M Montgomery; John W Sanders; Andres G Lescano Journal: Am J Trop Med Hyg Date: 2015-04-06 Impact factor: 2.345
Authors: Abdu A Adamu; Olalekan A Uthman; Elvis O Wambiya; Muktar A Gadanya; Charles S Wiysonge Journal: Hum Vaccin Immunother Date: 2019-04-22 Impact factor: 3.452
Authors: Aaron S Wallace; Kathleen Wannemuehler; George Bonsu; Melissa Wardle; Mawuli Nyaku; Kwame Amponsah-Achiano; John F Dadzie; Frederick O Sarpong; Walter A Orenstein; Eli S Rosenberg; Saad B Omer Journal: Vaccine Date: 2019-01-11 Impact factor: 3.641
Authors: Stephen N Wong; Janus P Ong; Madalinee Eternity D Labio; Oscar T Cabahug; Maria Lourdes O Daez; Erlinda V Valdellon; Jose D Sollano; Marilyn O Arguillas Journal: World J Hepatol Date: 2013-04-27